Two recent UPC decisions have provided some guidance on the admissibility and reasonableness of auxiliary requests in revocation actions. The ...

What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many ...

Sand Hill Road Host Scott McGrew spoke with Jim Tananbaum to learn more about how artificial intelligence is fueling ...

Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...

Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage ...

Parse’s chromatin accessibility technology leverages a novel approach with advantages over existing methods such as ATAC-seq ...

Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future ...

Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the ...

Xiaomi Redmi 10X 5G is officially announced in May 2020. The smartphone is fueled by a Non-removable Li-Po 4520 mAh battery + Fast charging 22.5W. The phone runs on the Android 10.0 + MIUI 11 ...

Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with ...

Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived ...